Johnson & Johnson Profit Rises 20%
From Reuters
Johnson & Johnson said third-quarter earnings rose 20% on sizzling sales of its prescription drugs and medical devices, including a new stent to clear clogged arteries.
The maker of Tylenol and Band-Aids posted a profit of $2.07 billion, or 69 cents a share, compared with $1.72 billion, or 57 cents, a year earlier. Revenue rose 15% to $10.5 billion.
Shares of New Brunswick, N.J.-based J&J; rose $1.14 to $50.93 on the New York Stock Exchange.
